Adverse events16

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 16 of 16

Type	Event	Organ system	Group	Affected	At risk
other	Paresthesia	Nervous system disorders	Topiramate	9	16
other	Paresthesia	Nervous system disorders	Placebo	0	18
other	Dysgeusia	Nervous system disorders	Topiramate	5	16
other	Dysgeusia	Nervous system disorders	Placebo	0	18
other	Cognitive Dysfunction	General disorders	Topiramate	5	16
other	Cognitive Dysfunction	General disorders	Placebo	1	18
other	Daytime Tiredness	General disorders	Topiramate	5	16
other	Daytime Tiredness	General disorders	Placebo	3	18
other	Decreased Daytime Apetite	Metabolism and nutrition disorders	Topiramate	3	16
other	Decreased Daytime Apetite	Metabolism and nutrition disorders	Placebo	1	18
other	Dry Mouth	General disorders	Topiramate	3	16
other	Dry Mouth	General disorders	Placebo	0	18
other	Nausea	General disorders	Topiramate	1	16
other	Nausea	General disorders	Placebo	0	18
other	Headache	General disorders	Topiramate	2	16
other	Headache	General disorders	Placebo	1	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00606411/events